HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).

Abstract
A prospective multicenter trial has been started in Korea to evaluate the diagnostic accuracy of endometrial aspiration biopsy compared with dilatation and curettage in patients treated with progestin for endometrial hyperplasia. For conservative treatment of endometrial hyperplasia, orally administered progestins are most commonly used method with various treatment regimens and more recently, the levonorgestrel-releasing intrauterine system also has been used successfully to treat endometrial hyperplasia. However, there is no report about the accuracy of endometrial sampling during hormonal treatment for follow-up evaluation of endometrial hyperplasia. Patients with histologically confirmed endometrial hyperplasia are offered hormonal treatment with any one of the following three options: oral medroxyprogesterone acetate 10 mg/day for 14 days per cycle, continuous oral medroxyprogesterone acetate 10 mg/day or insertion of levonorgestrel-releasing intrauterine system. Histological surveillance is performed at 3 months or 6 months following initial treatment. Endometrial tissues are obtained via endometrial aspiration biopsy using a pipelle and dilatation and curettage. In the case of levonorgestrel-releasing intrauterine system, endometrial aspiration biopsy will be done with levonorgestrel-releasing intrauterine system in uterus and then, after the removal of levonorgestrel-releasing intrauterine system, dilatation and curettage will be done. The biopsy findings will be compared. The primary endpoint is to compare the pathological outcome of endometrial aspiration with dilatation and curettage. The secondary endpoint is the response rate with three types of progestin treatment at 6 months.
AuthorsMi Kyoung Kim, Seok Ju Seong, Taek Sang Lee, Kyung-Do Ki, Myong Cheol Lim, Yun Hwan Kim, Kidong Kim, Won Duk Joo
JournalJapanese journal of clinical oncology (Jpn J Clin Oncol) Vol. 45 Issue 10 Pg. 980-2 (Oct 2015) ISSN: 1465-3621 [Electronic] England
PMID26206899 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Copyright© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • Contraceptive Agents, Female
  • Levonorgestrel
  • Medroxyprogesterone
Topics
  • Adult
  • Biopsy, Fine-Needle (methods)
  • Contraceptive Agents, Female (therapeutic use)
  • Curettage
  • Endometrial Hyperplasia (diagnosis, drug therapy)
  • Endometrium (surgery)
  • Female
  • Humans
  • Intrauterine Devices, Medicated
  • Levonorgestrel (therapeutic use)
  • Medroxyprogesterone (therapeutic use)
  • Middle Aged
  • Prospective Studies
  • Republic of Korea

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: